Rossari Biotech Balance Sheet Annual
BSE: - | NSE: - | ISIN: - | Sector: -513.40 +1.70 (0.33%)Updated : 09 Jun 2026
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 2,288.79 | 1,896.18 | 1,572.15 | 1,367.57 |
| Cash Equivalents | 92.21 | 0.00 | 13.10 | 57.24 |
| Other Liabilities Total | 8.26 | 5.26 | 3.98 | 10.24 |
| Long Term Debt | 94.33 | 100.03 | 33.32 | 34.93 |
| Common Stock Total | 11.08 | 11.07 | 11.05 | 11.03 |
| Other Current Assets Total | 147.34 | 14.40 | 3.39 | 2.88 |
| Total Assets | 2,288.79 | 1,896.18 | 1,572.15 | 1,367.57 |
| Current Portof LT Debt/ Capital Leases | 321.36 | 9.55 | 12.03 | 9.98 |
| Total Equity | 1,333.35 | 1,185.45 | 1,047.73 | 915.17 |
| Long Term Investments | 51.59 | 26.77 | 25.36 | 25.20 |
| Retained Earnings( Accumulated Deficit) | 1,322.27 | 699.29 | 568.05 | 440.08 |
| Total Common Shares Outstanding | 5.54 | 5.54 | 5.52 | 5.52 |
| Tangible Book Valueper Share Common Eq | 200.32 | 169.90 | 142.07 | 116.13 |
| Goodwill Net | 118.71 | 118.71 | 118.71 | 118.71 |
| Total Liabilities | 955.44 | 710.74 | 524.42 | 452.40 |
| Total Debt | 435.94 | 218.00 | 118.79 | 73.93 |
| Short Term Investments | 41.02 | 60.85 | 45.64 | 81.06 |
| Cashand Short Term Investments | 133.23 | 105.06 | 70.82 | 150.26 |
| Total Receivables Net | 558.57 | 515.57 | 462.51 | 367.59 |
| Deferred Income Tax | 43.05 | 46.57 | 51.47 | 58.72 |
| Accounts Receivable- Trade Net | 557.41 | 474.79 | 425.29 | 354.20 |
| Property/ Plant/ Equipment Total- Net | 733.84 | 493.72 | 361.90 | 326.68 |
| Total Current Liabilities | 789.56 | 536.57 | 424.74 | 348.51 |
| Total Inventory | 404.54 | 406.10 | 306.82 | 198.87 |
| Accounts Payable | 323.45 | 286.34 | 219.10 | 181.02 |
| Other Currentliabilities Total | 144.75 | 144.08 | 128.36 | 121.68 |
| Total Long Term Debt | 114.58 | 122.34 | 44.23 | 34.93 |
| Intangibles Net | 105.20 | 126.10 | 144.15 | 155.92 |
| Other Long Term Assets Total | 23.79 | 17.75 | 8.21 | 6.12 |
| Note Receivable- Long Term | 11.98 | 70.00 | 69.04 | 13.51 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 1,243.68 | 1,043.14 | 844.79 | 721.42 |
| Capital Lease Obligations | 20.25 | 22.31 | 10.91 | 0.00 |
| Accumulated Depreciation Total | - | -201.28 | -156.36 | -121.96 |
| Accrued Expenses | - | 10.49 | 2.72 | 6.81 |
| Other Equity Total | - | 0.00 | - | - |
| Prepaid Expenses | - | 2.01 | 1.25 | 1.83 |
| Additional Paid- In Capital | - | 475.08 | 468.63 | 464.06 |
| Cash | - | 44.20 | 12.07 | 11.96 |
| Property/ Plant/ Equipment Total- Gross | - | 554.81 | 471.05 | 435.57 |
| Notes Payable/ Short Term Debt | - | 86.11 | 62.53 | 29.01 |
*All figures in crores except per share values
Rossari Biotech Quick Links
Rossari Biotech Dividend Rossari Biotech Bonus Rossari Biotech News Rossari Biotech AGM Rossari Biotech Rights Rossari Biotech Splits Rossari Biotech Board Meetings Rossari Biotech Key Metrics Rossari Biotech Shareholdings Rossari Biotech Profit Loss Rossari Biotech Cashflow Rossari Biotech Q1 Results Rossari Biotech Q2 Results Rossari Biotech Q3 Results Rossari Biotech Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
386.70+13.70(3.67%)
1,460.05+25.20(1.76%)
250.80+3.05(1.23%)
4,239.20-59.90 (-1.39%)
2,278.00-29.75 (-1.29%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.